How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The "forgotten adjunct therapy": the link between ESA use and control of hyperparathyroidism in chronic kidney disease.
| Image |  |
|---|---|
| Description | scientific article published on 05 June 2013 |
| Author/s |
author: Marisa Battistella |
| Publication date | June 5, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |